KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Shares Issued (2016)

Bristol Myers Squibb has reported Shares Issued over the past 8 years, most recently at $37.0 million for Q4 2016.

  • Quarterly Shares Issued rose 5.71% to $37.0 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $181.0 million through Dec 2016, down 31.95% year-over-year, with the annual reading at $181.0 million for FY2016, 31.95% down from the prior year.
  • Shares Issued was $37.0 million for Q4 2016 at Bristol Myers Squibb, up from $12.0 million in the prior quarter.
  • Over five years, Shares Issued peaked at $270.0 million in Q1 2013 and troughed at $12.0 million in Q3 2016.
  • The 5-year median for Shares Issued is $63.5 million (2012), against an average of $88.1 million.
  • Year-over-year, Shares Issued skyrocketed 200.0% in 2012 and then plummeted 83.82% in 2014.
  • A 5-year view of Shares Issued shows it stood at $66.0 million in 2012, then increased by 22.73% to $81.0 million in 2013, then dropped by 27.16% to $59.0 million in 2014, then plummeted by 40.68% to $35.0 million in 2015, then grew by 5.71% to $37.0 million in 2016.
  • Per Business Quant, the three most recent readings for BMY's Shares Issued are $37.0 million (Q4 2016), $12.0 million (Q3 2016), and $61.0 million (Q2 2016).